ClinicalTrials.Veeva

Menu

Digital Health Intervention for Caregivers Emotional and Self-management Support of Children With Type 1 Diabetes (CARING-T1D)

A

Adhera Health

Status

Completed

Conditions

Diabetes Mellitus, Type 1

Treatments

Behavioral: Adhera® Caring digital intervention for Type 1 Diabetes

Study type

Interventional

Funder types

Other
Industry

Identifiers

NCT05483803
CAR-22-001
U1111-1280-9100 (Registry Identifier)

Details and patient eligibility

About

This feasibility study builds upon mental health and technology acceptance theoretical frameworks. It seeks to examine potentials of a mobile-based novel digital health solution based on emotional and behavioral change techniques, to provide emotional and self-management tailored support to caregivers of children with type I diabetes (T1D).

The digital health program, called Adhera® Caring, is designed to be used for approximately 3 months. The study will enroll 100 participants (20 in sub-study 1 and 80 in sub-study 2) who are caregivers of children with type 1 diabetes. There will be a nurse coaching the participants by providing support related to their emotional wellbeing via the mobile solution.

Full description

Objectives:

  • Primary objective 1. To gather qualitative and quantitative information enabling to better understand psychological burdens that caregivers of children with type 1 diabetes and perceived barriers/facilitators for adoption of a digital health solution.
  • Primary objective 2. To assess positive mood states of caregivers of type 1 diabetes patients as an indicator of emotional wellbeing related to the use of the digital health solution.

This is a prospective mixed-methods (qualitative-quantitative) exploratory study composed of two sub-studies:

  • Qualitative sub-study 1 (SS1): One group of caregivers (n = 20) will engage with the digital health solution for 1 month. Subsequently, an individual semi-structured interview with each of the participants and a usability questionnaire will proceed to gather user experience qualitative information.
  • Quantitative sub-study 2 (SS2): A different group of caregivers (n = 80) will engage with the digital health solution for 3 months. As elaborated in the following sections, a quantitative approach will be adopted to assess different emotional and behavioral parameters before and after engaging with the digital health solution (pre-post design).

Enrollment

100 patients

Sex

All

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Caregiver of patients with type 1 diabetes under 18 years of age.
  • Patient's debut of type 1 diabetes at least 3 months prior to the start of the study.
  • Patients with continuous glucose monitoring.
  • Participants with children undergoing insulin treatments (multiple dose insulin or continuous subcutaneous insulin infusion)
  • Participants administering insulin treatment to their children
  • Users of smartphone whose children are treated with type 1 diabetes treatment for approved indications in Spain.
  • Participants must agree on sharing data on continuous glucose monitoring data of their treated children.
  • Participants must sign an informed consent
  • Participants must be willing to and install the mobile solution of the study.

Exclusion criteria

  • Candidates without a smartphone or not being able to interact with it.
  • Only one legal guardian per child can participate in the study.
  • Participants of SS1 will not take part in SS2.

Trial design

Primary purpose

Other

Allocation

Non-Randomized

Interventional model

Sequential Assignment

Masking

None (Open label)

100 participants in 2 patient groups

Qualitative sub-study 1 group
Experimental group
Description:
One group of caregivers (n = 20) will engage with the digital health solution during 1 month.
Treatment:
Behavioral: Adhera® Caring digital intervention for Type 1 Diabetes
Quantitative sub-study 2 group
Experimental group
Description:
A different group of caregivers (n = 80) will engage with the digital health solution during 3 months.
Treatment:
Behavioral: Adhera® Caring digital intervention for Type 1 Diabetes

Trial contacts and locations

1

Loading...

Central trial contact

Julia Lopez Guimet, PhD; Luis Fernandez Luque, PhD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems